Navigation Links
Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
Date:2/10/2009

SEATTLE, Feb. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (NASDAQ and MTA: CTIC) today announced that they have executed a definitive collaborative agreement with IDIS to manage its investigational drug pixantrone on a named patient basis in Europe. Pixantrone will be supplied by IDIS to healthcare professionals for the treatment of individual patients with relapsing aggressive non-Hodgkin's lymphoma. This program is expected to be initiated by second quarter of 2009.

"Under the named patient program, CTI will be able to provide pixantrone to European patients in need at the prescriber's request while moving it through the approval process in the United States," noted Craig Philips, President of CTI. "With the announcement of preliminary results showing significantly higher rate of complete remission and improvement in progression-free survival for patients receiving pixantrone compared to standard chemotherapeutic agents, we expect to receive a number of requests for pixantrone to treat specific patients."

"Pixantrone is an important new treatment with impressive remission and progression-free survival data," said Dr. Raul Herbrecht of Strasbourg University Hospital in France. "This drug is also important because it meets an unmet medical need for this group of patients. I have been impressed by the good tolerance and efficacy of pixantrone since the first clinical trial we had with this drug in our department. We obtained excellent results in salvage therapy of non-Hodgkin's lymphoma in heavily pretreated patients and several years later some of our patients are still in complete response. These positive results have been confirmed in further studies," Dr Herbrecht added.

The EXTEND clinical trial was a phase III single-agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or more prior therapies and who were sensitive to treatment with anthra
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
2. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
5. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
6. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
7. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
8. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Germany , Aug. 21, 2014  IBM (NYSE: ... Elektronen-Synchrotron ( DESY ), a leading national research center ... management and storage of massive volumes of x-ray data. ... based on IBM software defined technology can handle more ... performance and help scientists worldwide gain faster insights into ...
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
(Date:8/21/2014)... 2014  Armada Health Care (Armada), the nation,s ... pleased to announce an agreement with Aurora Health ... innovative specialty pharmacy patient program offerings. The new ... services to specialty patients via Armada,s proprietary ReachRx ... will use the OTM platform as its case ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3
(Date:8/21/2014)... Pulmonary Hypertension Association goes on ... for PH patients and families to help fight ... Association – the country’s leading pulmonary hypertension ... and cure pulmonary hypertension (PH) – a disease ... the heart and can lead right to heart ...
(Date:8/21/2014)... source of fungal infections that have been sickening HIV/AIDS ... on trees. , The discovery is based on the ... summer gathering soil and tree samples from areas around ... named Cryptococcus gattii (CRIP-to-cock-us GAT-ee-eye). ... species including C. gattii , causes life-threatening infections ...
(Date:8/21/2014)... News) -- Black mothers are less likely than white ... reason why: Hospitals in neighborhoods with many black residents ... with more white residents, a U.S. government study finds. ... common in medical centers where the black population is ... Disease Control and Prevention reported Thursday. These practices ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
(Date:8/21/2014)... 21, 2014 Transvaginal mesh lawsuits ... continue to move forward in the federal multidistrict ... of West Virginia, Bernstein Liebhard LLP reports. According ... the Court has established new stipulated evidence preservation ... division, storage and preservation. (In re C.R. Bard ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3
... statin in a major trial that ended in 2003 is ... participants in both groups have been taking statins ever since. ... the statin was so effective at preventing heart attacks and ... on, the most significant difference between the groups is a ...
... immune cell invaluable in fighting some infections also can be exploited ... In papers published online in Immunity , scientists at Washington ... known as CD8 alpha+ dendritic cells (CD8a+ DCs), can help the ... cells can be hijacked by a bacterium to decimate the body,s ...
... Reporter , FRIDAY, Aug. 26 (HealthDay News) -- Almost a ... were ever married have had affairs -- twice the rate ... It,s not clear, however, whether serving in the military played ... findings do suggest that service members, veterans and their spouses ...
... status are much more likely to develop heart disease than ... recent UC Davis study. Published online in BMC Cardiovascular ... even with long-term progress in addressing traditional risk factors such ... "Being poor or having less than a high school education ...
... Aerobic exercise is better than resistance training if you want ... to your health, researchers say. That,s the finding of ... (such as jogging), resistance training (such as weight lifting), or ... adults aged 18 to 70. The participants in the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- A build-up of ... the brain may be linked with brain changes that increase ... Researchers used CT scans to check 885 people, average ... the coronary arteries that provide blood to the heart; the ...
Cached Medicine News:Health News:Statins reduce deaths from infection and respiratory illness, 8 years on from trial 2Health News:Rare immune cell is asset and liability in fighting infection 2Health News:Rare immune cell is asset and liability in fighting infection 3Health News:Service Members Twice as Likely to Have Affairs: Study 2Health News:Service Members Twice as Likely to Have Affairs: Study 3Health News:Lower socioeconomic status linked with heart disease despite improvements in other risk factor 2Health News:Jogging Beats Weight Lifting for Losing Belly Fat: Study 2Health News:Calcified Plaque in Arteries May Be Tied to Stroke, Dementia Risk 2
... with a 10-foot, kink-resistant cord for easier, ... electrosurgical pencils are the only product on ... non-stick tips allowing surgeons to make cleaner ... CLEAN PTFE coating is proven to last ...
... it maximizes use by allowing two ... while the third lamp is reserved ... in mind, it includes universal turrets ... excellent choice for hospital operating rooms ...
... The patented Applied Fiberoptics Gemini surgical headlight ... The headlight is durable and ultra-low-profile and ... closely without the annoying "rams effect." The ... nylon, is designed to sit low on ...
... use of some micro vascular clamps can ... With use, Stainless steel changes its elasticity, ... that pressures above 30g/mm2 may be associated ... from titanium which does not change its ...
Medicine Products: